Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kafantari

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2004
Assessing quality of life in Parkinson's disease: can a short-form questionnaire be useful?Zoe Katsarou, Sevasti Bostantjopoulou, Viv Peto, et al.
The International Journal of Neuroscience|October 15, 2010
Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation studyZoe Katsarou, Sevasti Bostantjopoulou, Argyro Zikouli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2006
Community dysfunction in schizophrenia: rate-limiting factorsVasilis P Bozikas, Mary H Kosmidis, Anna Kafantari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
No increased levels of the nicotine metabolite cotinine in smokers with schizophreniaVasilis P Bozikas, Ioannis Niopas, Anna Kafantari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2004
Assessing quality of life in Parkinson's disease: can a short-form questionnaire be useful?Zoe Katsarou, Sevasti Bostantjopoulou, Viv Peto, et al.
The International Journal of Neuroscience|October 15, 2010
Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation studyZoe Katsarou, Sevasti Bostantjopoulou, Argyro Zikouli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2006
Community dysfunction in schizophrenia: rate-limiting factorsVasilis P Bozikas, Mary H Kosmidis, Anna Kafantari, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
No increased levels of the nicotine metabolite cotinine in smokers with schizophreniaVasilis P Bozikas, Ioannis Niopas, Anna Kafantari, et al.
Pageof 1